AlphAIalphai — Financial news for AI agents
GlobeNewswireNOV 132 min read$ULBI

Ultralife Corporation to Report Third Quarter Results on November 18, 2025

NEWARK, N.Y., Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- Ultralife Corporation ( NASDAQ: ULBI ) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025.

Original reporting
GlobeNewswire · Ultralife Corporation
Published Nov 13, 2025, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 13, 2025, 10:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Ultralife Corporation to Report Third Quarter Results on November 18, 2025 — source image
Source · www.globenewswire.com
Decision brief

The 30-second read

$ULBINeutralLow
01

Why it matters

Earnings results could influence short-term stock movement but are unlikely to alter long-term fundamentals.

02

Market read

The event is primarily relevant to investors and traders interested in ULBI; limited impact on broader markets.

03

What to watch

Broader market trends and macroeconomic factors could influence stock performance beyond earnings results.

Timing: short-term (within the next 1-3 days around November 18, 2025)

Background

Ultralife Corporation is a manufacturer specializing in batteries and power systems, with upcoming earnings scheduled for November 18, 2025.

Company-level read

Ticker impact

$ULBINeutralMedium confidence
Context

The upcoming earnings report is a scheduled event that could influence stock performance.

Expected impact

Potential for moderate volatility; possible slight upward or downward movement depending on earnings results.

Evidence & confidence

Earnings reports are significant catalysts, but the current market sentiment is neutral, and no unexpected news is anticipated. The impact depends on actual earnings versus expectations.

Market effects

Sector

Manufacturing sector may experience slight volatility due to earnings season activities.

Regional

Limited regional impact; specific to US markets where Ultralife is listed.

Global

Minimal; company-specific event with limited global implications.

Counterpoint

What could challenge this read

If earnings surpass expectations, ULBI stock could see a short-term rally, making it a potential buying opportunity.

Key entities

  • Company
    Ultralife Corporation

    A manufacturer of batteries and power systems.

Read at source← All news

Related articles

AUG 8
$ULBIMedAI 8/10

Ultralife (ULBI) Q2 2026 Earnings Call Transcript

Ultralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.

fool.com6 min
AUG 7
$ULBIMed

ULTRALIFE CORP (ULBI): Results of Operations and Financial Condition

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: ● Sales of $47.9 million compared to $48.6 mil

SEC EDGAR 8-K6 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min
SEP 8
$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

theyeshivaworld.com2 min
SEP 8
$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

yahoo.com2 min